EUVIMED · CrossrefJournal
Oncogenesis
ISSN 2157-9024 · Springer Science and Business Media LLC
Latest articles
Retraction Note: Growth-induced stress enhances epithelial-mesenchymal transition induced by IL-6 in clear cell renal cell carcinoma via the Akt/GSK-3β/β-catenin signaling pathway
Correction to: Paladin, overexpressed in colon cancer, is required for actin polymerisation and liver metastasis dissemination
Disruption of the AR/ZNF217/PROM2 axis sensitizes prostate cancer to ferroptosis and enzalutamide therapy
Obesity-driven extracellular vesicle signaling in cancer: mechanistic insights and clinical implications
Anti-apoptotic BCL-2 family proteins: from regulatory networks to therapeutic targeting
The emerging role of disulfidptosis in metabolic synergistic death and cancer immunotherapy
Tipping the balance: NRF2’s dual role in ferroptotic fate
Imbalances of mitochondrial dynamics in solid tumors
Metabolic modulation of immune cell function: mechanisms and therapeutic implications in cancer immunotherapy
Cyclin E modulates vulnerability to CDC7 kinase inhibition
The oncogenic control of nucleotide synthesis
C1s protects cutaneous squamous carcinoma cells from TRAIL-induced apoptosis
Fatty acid uptake mediated by FABP4 promotes the formation of CD8+T cell senescence through lipid peroxidation in the adipocyte-rich microenvironment of Ovarian Cancer
Common gene mutations in 103 authenticated colorectal cancer cell lines
Iron and metabolic rewiring in cancer
Targeting mitochondrial phosphatidylethanolamine alters mitochondrial metabolism and proliferation in hepatocellular carcinoma
Stabilization of FASN by USP5-mediated deubiquitination promotes hepatocellular carcinoma progression
ACSL6 modulates docosahexaenoic acid-induced cytotoxicity to potentiate chemotherapy response in colorectal and breast cancer
YTHDF3 promotes breast cancer osteolytic bone metastasis by enhancing the translation of ZEB1 and SMAD5
Targeting macrophage migration inhibitory factor as a potential therapeutic strategy in colorectal cancer
Lipid droplet-associated hydrolase (LDAH) knockdown enhances TAG hydrolysis and promotes ovarian cancer progression and chemoresistance
PLEKHA4 is transcriptionally regulated by HOXD9 and regulates glycolytic reprogramming and progression in glioblastoma via activation of the STAT3/SOCS-1 pathway
MYCN and KAT2A form a feedforward loop to drive an oncogenic transcriptional program in neuroblastoma
The branched N-glycan of PD-L1 predicts immunotherapy responses in patients with recurrent/metastatic HNSCC
Tumor suppressor BAP1 suppresses disulfidptosis through the regulation of SLC7A11 and NADPH levels
Cell competition in primary and metastatic colorectal cancer
Gemcitabine as chemotherapy of head and neck cancer in Fanconi anemia patients
Comprehensive multi-omics analysis of breast cancer reveals distinct long-term prognostic subtypes
Progesterone receptor potentiates macropinocytosis through CDC42 in pancreatic ductal adenocarcinoma
PKC-independent PI3K signalling diminishes PKC inhibitor sensitivity in uveal melanoma
EUVIMED